Skip to main content
. 2013 Jun 9;61(9):522–527. doi: 10.1007/s11748-013-0263-z

Fig. 2.

Fig. 2

Strategy for identifying potentially resectable NSCLC. To more accurately determine N-stage, EBUS-TBNA was routinely performed in patients with radiologically node-positive disease or with a clinical status indicating potential for nodal metastasis. The modality is also applicable to the evaluation of treatment efficacy in potentially resectable N2 patients undergoing induction therapy